SILVERTHORNE, CO - August 11, 2015 - Keystone Symposia on Molecular and Cellular Biology has received a fifth three-year grant from the Bill & Melinda Gates Foundation to help fund conferences in its ...

SILVERTHORNE, CO – July 19, 2012 – Keystone Symposia on Molecular and Cellular Biology is pleased to announce that it has received a fourth grant from the Bill & Melinda Gates Foundation to promote ...

The conference will feature a provocative keynote address by Dr. Peter Hotez, titled "Vaccines and Immunizations in a Time of Global Boiling, Megacities, and Antiscience," addressing the growing ...

The Endocrine Society, a global organization that promotes endocrinology research and clinical practice, and Keystone Symposia, a nonprofit host of conferences and symposia on a range of life science ...

A conversation with Vishva Dixit, Vice President of Discovery Research at Genentech and board member of Keystone Symposia. Since 1972, Keystone Symposia has organized conferences spanning a broad ...

When Jane Peterson came on as CEO and president of the Keystone Symposia in April of 2014, one of her goals was to expand the organization’s global reach. A 501(c)3 nonprofit organization, the ...

Keystone Symposia on Molecular and Cellular Biology has received a 3- year grant of $2,599,679 to support an expansion of Keystone Symposia’s Global Health Series. For 35 years, Keystone Symposia has ...

at upcoming Keystone Symposia Conference: "Type I Interferon: Friend and Foe Alike" Paris and Boston, March 9, 2017 - Neovacs (Alternext Paris: ALNEV), a leader in active immunotherapies for the ...

SILVERTHORNE – Tucked away in a suite of offices above a thrift shop in Silverthorne, Keystone Symposia employs about 30 local people, has an annual operating budget of about $15 million and brings ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cellino, a regenerative medicine company developing autonomous manufacturing systems for personalized cells, today announced that the company has been invited to ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Orpheris, a clinical stage neuroscience company leveraging a novel platform technology that enables the selective delivery of therapeutic agents across the blood ...